The multidisciplinary melanoma clinic: A cost outcomes analysis of specialty care

Journal of the American Academy of Dermatology

Volumn 38, Issue 5 I, 1998, Pages 742-751

  Fader, D J ^a   Wise, C G ^a   Normolle, D P ^a   Johnson, T M ^a  

^a UNIVERSITY OF MICHIGAN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; CANCER SURVIVAL; COMMUNITY CARE; CONTROLLED STUDY; COST BENEFIT ANALYSIS; COST EFFECTIVENESS ANALYSIS; FEMALE; HEALTH CARE DELIVERY; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MELANOMA; PRIORITY JOURNAL; REVIEW; TREATMENT OUTCOME;

EID: 0031954150     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0190-9622(98)70203-8     Document Type: Article

References (43)

1. DS Rigel RJ Friedman AW Kopf The incidence of malignant melanoma in the United States: issues as we approach the 21st century J Am Acad Dermatol 34 1996 839 847
2. SL Parker T Tong S Bolden Cancer statistics, 1996 CA Cancer J Clin 47 1997 5 27
3. TM Johnson JW Smith BR Nelson A Chang Current therapy for cutaneous melanoma J Am Acad Dermatol 32 1995 689 707
4. LA Glocker-Reis BA Miller BF Hankey SEER cancer statistics review, 1973-1991: tables and graphs 1994 National Institutes of Health Bethesda (MD) Pub No. 94-2789
5. HK Koh RW Clapp JM Barnett WM Nannery SR Tahan AC Geller Systematic underreporting of cutaneous malignant melanoma in Massachusetts J Am Acad Dermatol 24 1991 545 550
6. HK Koh A Geller DR Miller RW Clapp RA Lew Underreporting of cutaneous melanoma in cancer registries nationwide [letter] J Am Acad Dermatol 27 1992 1035 1036
7. TG Salopek AA Marghoob JM Slade B Rao DS Rigel A Kopf An estimate of the incidence of malignant melanoma in the United States based upon a survey of the members of the American Academy of Dermatology Dermatol Surg 21 1995 301 305
8. RC Wender Barriers to effective skin cancer detection Cancer 75 1995 691 698
9. K Nagy New database allows researchers to evaluate cancer care costs J Natl Cancer Inst 85 1993 351 353
10. MD Brown TM Johnson NA Swanson Changing trends in melanoma treatment and the expanding role of the dermatologist Dermatol Clin 9 1991 657 667
11. CG Wise JE Billi A model for practice guideline adaptation and implementation: empowerment of the physician Jt Comm J Qual Improv 21 1995 465 476
12. DM Eddy Designing a practice policy: standards, guidelines, and options JAMA 263 1990 3077 3084
13. DM Eddy Practice policies: guidelines for methods JAMA 263 1990 1839 1841
14. RS Hayward MC Wilson SR Tunis EB Bass HR Rubin RB Haynes More informative abstracts of articles describing clinical practice guidelines Ann Intern Med 118 1993 731 737
15. RM Wachter L Goldman The emerging role of “hospitalists” in the American health care system N Engl J Med 335 1996 514 516
16. MW Rich V Beckham C Wittenberg CL Leven KE Freedland RM Carney A multidisciplinary intervention to prevent the readmission of elderly patients with congestive heart failure N Engl J Med 333 1995 1190 1195
17. LA Drake RI Ceilley RL Cornelison WL Dobes WA Dorner RW Goltz Guidelines of care for malignant melanoma J Am Acad Dermatol 28 1993 638 641
18. National Institutes of Health Consensus Conference Diagnosis and treatment of early melanoma JAMA 268 1992 1314 1319
19. SJ Hoffman JJ Yohn DA Norris CM Smith WA Robinson Cutaneous malignant melanoma Curr Probl Dermatol 5 1993 1 44
20. KH Koh Cutaneous melanoma N Engl J Med 325 1991 171 182
21. Changing trends in the clinical and pathologic features of melanoma 2nd ed CM Balch AN Houghton GW Milton AJ Sober SJ Soong Cutaneous melanoma 1992 JB Lippincott Philadelphia 40 45
22. MM Urist LH Karnell The National Cancer Database – report on melanoma Cancer 74 1994 782 788
23. EF McClay K Hunger Melanoma: new biology; new therapy Crit Rev Oncol Hematol 11 1991 299 314
24. Physician’s current procedural terminology, CPT ‘96 1996 American Medical Association Chicago
25. Department of Health and Human Services The international classification of diseases, 9th rev., clinical modification: ICD-9-CM 2nd ed 1980 Government Printing Office Washington (DC) DHHS Pub No. 80-1260
26. T Futoryan D Grande Postoperative wound infection rates in dermatologic surgery Dermatol Surg 21 1995 509 514
27. DC Whitaker DJ Grande SS Johnson Wound infection rate in dermatologic surgery J Dermatol Surg Oncol 14 1988 525 528
28. TJ Smith C Balch A Bartolucci C Karakousis M Ross M Urist Morbidity of primary surgery for malignant melanoma (poster session) 1995 Society of Surgical Oncology, Boston
29. CM Balch MM Urist CP Karakousis TJ Smith WJ Temple K Drzewiecki Efficacy of 2 cm surgical margins for intermediate-thickness melanomas (1-4 mm): results of a multi-institutional randomized surgical trial Ann Surg 218 1993 262 269
30. WG Bowsher BA Taylor LE Hughes Morbidity, mortality and local recurrence following regional node dissection for melanoma Br J Surg 73 1986 906 908
31. JHF Shaw J Koea Morbidity of lymphadenectomy for melanoma Surg Oncol Clin North Am 1 1992 195 203
32. CP Karakousis DL Driscoll B Rose DL Walsh Groin dissection in malignant melanoma Ann Surg Oncol 1 1994 271 277
33. KI Bland TW Klamer HC Polk CO Knutson Isolated regional lymph node dissection. Morbidity, mortality and economic considerations Ann Surg 193 1981 372 376
34. PC Baas HS Koops HJ Hoekstra JJ van Bruggen LT van der Weele J Oldhoff Groin dissection in the treatment of lower-extremity melanoma: short-term and long-term morbidity Arch Surg 127 1992 281 286
35. CP Karakousis W Goumas U Rao DL Driscoll Axillary node dissection in malignant melanoma Am J Surg 162 1991 202 207
36. MM Urist WA Maddox JE Kennedy CM Balch Patient risk factors and surgical morbidity after regional lymphadenectomy in 204 melanoma patients Cancer 51 1983 2152 2156
37. Malignant melanoma of the skin (excluding eyelid) 4th ed OH Beahrs DE Henson RVP Hutter BJ Kennedy American Joint Committee on Cancer Manual for Staging of Cancer 1992 JB Lippincott Philadelphia 143 148
38. MA Testa DC Simonson Assessment of quality-of-life outcomes N Engl J Med 334 1996 835 840
39. RH Brook EA McGlynn PD Cleary Part 2: Measuring quality of care N Engl J Med 335 1996 966 970
40. M Weiss CL Loprinzi ET Creagan RJ Dalton P Novotny JR O’Fallon Utility of follow-up tests for detecting recurrent disease in patients with malignant melanomas JAMA 274 1995 1703 1705
41. N Basseres JJ Grob MA Richard X Thirion H Zarour C Noe Cost-effectiveness of surveillance of stage I melanoma: a retrospective appraisal based on a 10-year experience in a dermatology department in France Dermatology 191 1995 199 203
42. AC Buzaid AB Sandler S Mani AM Curtis W Poo JL Bolognia Role of computed tomography in the staging of primary melanoma J Clin Oncol 11 1993 638 643
43. T Khansur J Sanders SK Das Evaluation of staging work-up in malignant melanoma Arch Surg 124 1989 847 849